Literature DB >> 7499508

Increased antibody production in peripheral blood mononuclear cells after plasma exchange therapy in multiple sclerosis.

P C Dau1.   

Abstract

It has been difficult to study antibody synthesis in vivo following plasma exchange (PE) because of the intra- and extravascular compartmentation of immunoglobulins, and their altered lymphatic flow and catabolism after the procedure. There is fragmentary experimental and clinical evidence that antibody synthesis may increase due to removal of autoregulatory factors by PE. The present study showed increased in vitro spontaneous immunoglobulin (Ig) G and IgM production, as well as increased spontaneous lymphocytic proliferation, after intensive PE in 10 multiple sclerosis (MS) patients. Cytofluorometric control of cultured mononuclear cell populations revealed no change with treatment except for a small increase in B lymphocytes inadequate to account for the increased immunoglobulin production. These findings indicate an activation of the immune system through PE, and suggest the possible need for adjunctive immunosuppression to control antibody production in autoimmune diseases with subacute, relapsing, or chronic courses when PE is employed as a therapeutic modality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499508     DOI: 10.1016/0165-5728(95)00121-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  Can plasma exchange therapy induce regulatory T lymphocytes in multiple sclerosis patients?

Authors:  A Jamshidian; M Gharagozloo
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

2.  Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients.

Authors:  Chisa Yamada; Daniel S Ramon; Marilia Cascalho; Randall S Sung; Alan B Leichtman; Milagros Samaniego; Robertson D Davenport
Journal:  Transfusion       Date:  2014-11-11       Impact factor: 3.157

Review 3.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

Review 4.  B cells: no longer the nondominant arm of multiple sclerosis.

Authors:  Eric C Klawiter; Anne H Cross
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 6.030

Review 5.  Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Authors:  Yuting Jiang; Xin Tian; Yixue Gu; Feng Li; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

Review 6.  The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review.

Authors:  Saiju Jacob; Gordon Mazibrada; Sarosh R Irani; Anu Jacob; Anna Yudina
Journal:  J Neuroimmune Pharmacol       Date:  2021-10-02       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.